Study on Daily Sodium Butyrate Tablets to Reduce Menstrual Symptoms in Women

What this Trial Is About

This research aims to study the effects of Sodium Butyrate NaBu, a dietary supplement, on menstrual symptoms in women. The study focuses on common symptoms such as abdominal or pelvic cramping, lower back pain, bloating, mood swings, and irritability, which are thought to be linked to estrogen production in certain cells. Researchers believe that NaBu may reduce these symptoms by inhibiting a key enzyme involved in estrogen synthesis. Participants will take 2.4 grams of Sodium Butyrate daily in tablet form for 12 weeks. They will self-administer the supplement and record their daily symptom severity using an electronic diary. The study compares symptom scores recorded before starting NaBu with those during the 12-week treatment to evaluate changes. During the study, participants will have regular follow-ups to monitor progress and any side effects. Researchers will measure changes in average menstrual symptom scores between the baseline period one menstrual cycle before starting NaBu and the treatment period. The total participation involves daily symptom tracking and supplement use over 12 weeks.

The NaBu Effect on Menstruation in Women